Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers.
The ELISpot and FluoroSpot Assay market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.
+ Market Dynamics
+ Drivers
+ Rising Global Incidence of Chronic Diseases
+ Increasing Vaccine Development to Address the Challenge of Antimicrobial Resistance
+ Technological Advancements in ELISpot and FluoroSpot Assay Kits and Analyzers
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584
The ELISpot and FluoroSpot market is segmented into assay kits, analyzers, and ancillary products. The assay kits are further subsegmented by utility, type, and analyte. In 2018, the assay kits segment is expected to account for the largest share of the market. The rising incidence of chronic diseases and technological advancements are driving the growth of this product segment.
The ELISpot and FluoroSpot market is segmented into diagnostic and research applications. In 2018, the diagnostic applications segment is expected to account for the larger share of the ELISpot and FluoroSpot market in 2018. The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.
View complete press release:-
https://www.marketsandmarkets.com/PressReleases/elispot-fluorospot-assay.asp
